IHH Healthcare unveils S$5 million programme to fund healthcare research and pilot projects
Funds under the Research Grant & Innovation Sandbox programme will be disbursed over five years, empowering IHH clinicians and employees to pursue clinical research and to pilot ground-up initiatives addressing critical health issues.
The group said that the fund has 'potential to grow further', depending on the strength of proposals and interest level.
The programme's first grant call was held in March and focused on oncology and chronic diseases, which Dr Prem Kumar Nair, group chief executive officer of IHH Healthcare, described as 'two of the most urgent and complex challenges facing healthcare today'.
Out of 55 submissions received, a grant governance committee comprising senior management and domain experts from IHH shortlisted seven research grant projects and eight innovation sandbox applications.
The shortlisted submissions include one project from IHH's Singapore market, four from its Malaysia market, nine from its India market and one from its Hong Kong market.
BT in your inbox
Start and end each day with the latest news stories and analyses delivered straight to your inbox.
Sign Up
Sign Up
Among these are a study that aims to enhance healthcare delivery for Type 2 diabetes patients at Gleneagles Hospital in Penang, a project related to kidney failure at Pantai Hospital in Kuala Lumpur and a project focusing on an artificial intelligence-powered health application for continuous chronic disease monitoring in Singapore.
Projects under the programme's clinical research track are expected to be completed within one year or up to a maximum of two years for 'complex cases', IHH said. Their findings and outcomes are to be published to contribute to wider healthcare literature on oncology and chronic diseases.
Meanwhile, projects under the innovation sandbox track will prioritise ideas that demonstrate 'clear impact', such as scalability across IHH's markets, cost savings, improved patient outcomes and better patient experiences, the group said.
IHH will open its next call for submissions in September.
Shares of IHH closed on Thursday 2 per cent or S$0.04 higher at S$2.03.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Times
a day ago
- Business Times
Most Singaporeans are unprepared and underinsured for long-term care: Singlife
[SINGAPORE] Only one in three Singaporeans have taken out additional insurance to cover the cost of long-term care, and more than half of them underestimate actual expenses, revealed a white paper by financial services provider Singlife. 'This is alarming, especially when the numbers have shown that more than half of those over 65 will likely need some form of long-term care in their lifetime,' said Pearlyn Phau, group chief executive of Singlife. She was speaking at the white paper launch event on Friday (Jul 25) morning. Singlife is one of three private long-term care insurance providers in the Republic. Long-term care refers to services typically required by individuals who need further care after being discharged from an acute hospital, as well as the elderly who may need help with daily needs. As the life expectancy of Singaporeans rises, Phau noted that a longer life span can bring new and complex challenges – not just financially, but emotionally for individuals, families and all of society. This inspired Singlife to delve deeper into the realities of long-term care and publish a white paper titled From Awareness to Action: Securing Long-Term Care for a Super-Aged Society, which presents findings drawn from its long-term care insurance claims data from 2010 to 2024. The white paper incorporates insights from two in-house research studies which surveyed 1,005 Singaporeans and permanent residents (PRs) aged 18 to 65 on perceptions for long-term care, as well as 1,075 Singaporeans and PRs – including 249 caregivers – to better understand experiences and challenges in dementia caregiving. BT in your inbox Start and end each day with the latest news stories and analyses delivered straight to your inbox. Sign Up Sign Up 'This white paper is a call to action for individuals, families and institutions to plan proactively, because the long-term care challenge is already at our doorstep,' added Phau. Significant gaps Singlife's research revealed a significant gap in both awareness and financial preparedness among Singaporeans regarding long-term care. While long-term care costs close to S$3,000 per month on average, Singlife found that more than half of those surveyed underestimate the amount. Since a similar study in 2018, costs have increased by S$628, reflecting an annual inflation rate of around 4 per cent. Given the prolonged nature of care and compounding inflation, these costs are likely to escalate even further. However, Singapore's national insurance schemes – namely ElderShield and CareShield Life – currently offer coverage of only up to S$662 per month. This leaves a significant shortfall that could be bridged by private long-term care supplementary insurance plans. Yet, two-thirds of Singaporeans aged 30 and above have not taken up such coverage and may have to rely on personal savings or family support, potentially placing additional strain on their retirement funds. This lack of preparedness is especially concerning given the typical duration of care. Singlife's claims data from 2010 to 2024 showed that individuals require long-term care for an average of 10 years. In some cases, the need is even longer, with Singlife's longest active claimant receiving monthly payouts for more than 15 years. Long-term care is not limited to seniors either, given the youngest claimant was just 32 years old at the time of their claim. Being prepared In light of these findings, the white paper puts forward a series of recommendations including a renewed focus on early detection, intervention and prevention of conditions such as strokes, which remain a leading cause of long-term care insurance claims. At the launch event, Singlife also hosted a panel discussion on preparing for the rising demand for long-term care individually and collectively. 'You have to be prepared financially and not think government grants will be enough, as healthcare costs are coming up quickly,' said panellist Jason Foo, chief executive at Dementia Singapore. This is where insurance plays a key role to protect oneself financially, he added. The sum assured for Singlife's long-term care products are as low as S$200 and its premiums can be drawn from one's Central Provident Fund, noted fellow panellist Helen Shen, group head of products at Singlife. She also highlighted that while many feel they are too young to sign up for such coverage, it is more financially sustainable to get insured as early as possible. 'You are not just protecting yourself, you are also protecting your loved ones who will have to look after you,' added Shen.
Business Times
2 days ago
- Business Times
Neuralink sees US$1 billion of revenue by 2031 in vast expansion
[BOSTON] Elon Musk's brain implant company Neuralink expects to put its chips in 20,000 people a year by 2031, generating at least US$1 billion in annual revenue, in a major ramp-up of its work to treat disease and gain unprecedented access to the human mind, according to documents reviewed by Bloomberg. Within six years, the company also plans to have about five large clinics in operation, with at least three versions of its device available, according to a recent presentation shown to investors. One version, Telepathy, is for enabling communication between the brain and machines; another, Blindsight, is aimed at giving vision to blind people; and a third, Deep, would treat tremors and Parkinson's disease. The financial projections, as well as the company's work in patients with tremors and Parkinson's, have not been previously publicly reported. Representatives for Musk and Neuralink did not immediately respond to a request for comment. The company's stated goals show the enormous scale of Musk's vision for Neuralink and the ambitious timeline on which he seeks to operate. Fewer than 10 people are publicly known to have Neuralink brain devices so far as part of clinical trials, and no patients have them to restore vision or treat Parkinson's. By 2029, the company expects to gain regulatory approval in the US for its Telepathy device, and it hopes to perform 2,000 surgeries a year and generate at least US$100 million in annual revenue, according to the documents. Then by 2030, Neuralink sees the launch of its sight-restoring chip Blindsight, expanding to 10,000 surgeries a year and bringing in over US$500 million. The figures assume 'a conservative reimbursement of US$50k per surgery', the documents show. BT in your inbox Start and end each day with the latest news stories and analyses delivered straight to your inbox. Sign Up Sign Up Neuralink has raised US$1.3 billion from investors and is now valued at US$9 billion, according to PitchBook. Brain-computer interface companies such as Neuralink have attracted significant attention and investment in recent years for potential medical applications. No devices are approved by US regulators for permanent use in humans, as companies are still working on gathering data on safety and effectiveness. Musk has hit a number of milestones with Neuralink, though he is also known for overstating how quickly he will be able to reach technological achievements. For example, in 2015, Musk said that Tesla cars would be able to drive themselves within three years. He moved the timeline back several times and finally launched Robotaxis for testing last month. As part of clinical trials, paralysed patients have used Neuralink devices to control computers, allowing them to browse the internet, play games, and edit videos. The company has also been testing its vision implant in monkeys. Several other brain implant companies are building and testing devices to stimulate or read data from the brain. No brain-computer interfaces are approved commercially for permanent implantation by the US Food and Drug Administration. BLOOMBERG
Business Times
4 days ago
- Business Times
A looming dairy drought will stunt the world's growth
IT IS every baby's first food, and we cannot get enough of it. The world produces close to a billion tonnes of milk each year – more than all the wheat or rice we grow. That lead is set to widen over the coming decade, with dairy consumption expected to grow faster than any other agricultural commodity. On a rapidly warming planet, this poses a host of problems. Consider demand. There are more than half a billion people under the age of four in developing countries, and about a third of them suffer from stunting – short stature that is associated with health, educational and economic problems in later life. Most could benefit from the policy first proposed by Scottish nutritionist John Boyd Orr in the 1920s: provision of dairy products to give them a more nutritionally rich diet. That is one of the main pillars of Indonesian President Prabowo Subianto's newly introduced free school meals programme, as my colleague Daniel Moss has written. Similar programmes have been set up in many states in India, as well as South Africa and Kenya. In terms of human welfare, we should be welcoming this trend. Dairy products are relatively expensive, and we consume more of them as we rise above the most basic subsistence levels. If South Asia, South-east Asia and sub-Saharan Africa are likely to see booming consumption over the coming decade, as the Organization for Economic Co-operation and Development forecast last week, it is largely a positive symptom of their long-awaited economic development. BT in your inbox Start and end each day with the latest news stories and analyses delivered straight to your inbox. Sign Up Sign Up The problem comes when you start looking at supply. Milk is mostly being produced in the wrong places for the young stomachs that need it. More than 90 per cent of children under four are in developing countries – but the same nations produce barely half of the world's milk. Europe alone represents a quarter of global output, and highly perishable dairy products are not much sold across borders. The total worldwide trade in whole milk powder, for instance – after a decade when China's hunger for baby formula upended the global dairy industry – accounts for about 2 per cent of raw milk. Even that limited commerce has been sufficient to upset local supply chains. In New Zealand, often likened to the Saudi Arabia of dairy thanks to its dominance in exports, demand from South-east Asian importers drove whole milk powder prices to a three-year high in May, while butter inflation is running above 50 per cent. With trade providing only limited relief, we are most likely to see shortages, as rising demand from developing countries is met with limited increases in supply. The world's milk deficit will hit 30 million tonnes by 2030, the International Dairy Federation warned in April. The IFCN Dairy Research Network, a separate group, still sees a 10.5 million tonne shortfall by the same date. That dairy drought will push prices beyond the reach of those who most need it. Climate change makes all of this worse. Rising temperatures will mean it is even harder for tropical and subtropical countries to be self-sufficient: Extreme heat can cut milk production by as much as 10 per cent, according to a study in the journal Science Advances earlier this month. Milk is also a major culprit in global warming, as well as a victim of it. Dairy cattle emissions, mostly from methane-dense burps as cows digest grass, amount to 2.1 billion tonnes of carbon dioxide a year, equivalent to what is caused by two-thirds of all cars. The shift to more production in developing nations will make this even worse. Pollution for each kilogram of raw milk in Africa and South Asia is three to four times higher than in developed countries, because the mechanised, intensive dairy farming practised in the rich world has a far lower carbon footprint. What can be done to fix this? Wealthy nations whose appetite for plant-based alternatives appears to be wavering should recommit to their shift away from livestock-based food. Far too much of our limited capacity to sustain dairy production is still being hogged by affluent populations, who have grown so jaded that we now use milk for luxuries like bodybuilding supplements as much as for basic nutrition. Relatively prosperous developing countries like China and Brazil can also up their game by moving to more intensive farming. They could get by with a third of their current dairy herd if they raised yields to developed-world levels. In India, the biggest dairy producer, the benefits could be even greater. Thanks to religious objections to the slaughter of cows after they stop producing, there are more than five million stray cattle roaming the streets, spreading disease, attacking people, getting hit by traffic and fuelling organised crime. A smaller, more intensively raised herd would shrink this bovine epidemic. Greater dairying of buffalo, which already produce about half of India's milk and are not considered sacred, would also help. One thing is certain, though: Exhorting poor countries to give up the nutritional benefits of dairy that their richer peers have enjoyed is repugnant, and bound to fail. If we want to reduce milk's carbon footprint, we are going to need to produce it more efficiently, rather than hoping the problem will just go away. BLOOMBERG
